Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
G3BP1, p Ser232 Antibody, Novus Biologicals™

Rabbit Polyclonal Antibody
Supplier: Novus Biologicals NB100819310.025ML
Description
G3BP1 Polyclonal specifically detects G3BP1 in Human samples. It is validated for Western Blot, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin.Specifications
G3BP1 (p Ser232) | |
Polyclonal | |
Unconjugated | |
phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, and 50% glycerol. with 0.02% Sodium Azide | |
ATP-dependent DNA helicase VIII, EC 3.6.1, EC 3.6.4.12, EC 3.6.4.13, G3BP-1, G3BPRas-GTPase-activating protein SH3-domain-binding protein, GAP binding protein, GAP SH3 domain-binding protein 1, GTPase activating protein (SH3 domain) binding protein 1, hDH VIII, HDH-VIII, MGC111040, ras GTPase-activating protein-binding protein 1, RasGAP-associated endoribonuclease G3BP | |
Rabbit | |
60 kDa | |
0.025 mL | |
Core ESC Like Genes, Phospho Specific, Stem Cell Markers | |
10146 | |
Human | |
IgG |
Immunocytochemistry, Immunohistochemistry, Western Blot, Immunofluorescence, Immunohistochemistry (Paraffin) | |
1.0 mg/mL | |
Western Blot 1:500-1:1000, Immunohistochemistry 1:50-1:100, Immunocytochemistry/Immunofluorescence 1:100-1:200, Immunohistochemistry-Paraffin 1:50-1:100 | |
Q13283 | |
G3BP1 | |
The antiserum was produced against synthesized phosphopeptide derived from human G3BP-1 around the phosphorylation site of serine 232 (S-S-SP-P-A). | |
Affinity Purified | |
RUO | |
Primary | |
G3BP-1 (specific to Phospho-Ser232) detects endogenous levels of G3BP-1 only when phosphorylated at serine 232. | |
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction